<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>BCR/ABL1 | Hematology</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Overview of the BCR/ABL1 Fusion Gene  Definition: The BCR-ABL1 fusion gene is an abnormal gene formed by a reciprocal translocation between chromosomes 9 and 22, denoted as t(9;22)(q34.1;q11.2)...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="BCR/ABL1 | Hematology">
<meta property="og:type" content="book">
<meta property="og:description" content="Overview of the BCR/ABL1 Fusion Gene  Definition: The BCR-ABL1 fusion gene is an abnormal gene formed by a reciprocal translocation between chromosomes 9 and 22, denoted as t(9;22)(q34.1;q11.2)...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="BCR/ABL1 | Hematology">
<meta name="twitter:description" content="Overview of the BCR/ABL1 Fusion Gene  Definition: The BCR-ABL1 fusion gene is an abnormal gene formed by a reciprocal translocation between chromosomes 9 and 22, denoted as t(9;22)(q34.1;q11.2)...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="active" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Hematology/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="bcrabl1" class="section level1 unnumbered">
<h1>BCR/ABL1<a class="anchor" aria-label="anchor" href="#bcrabl1"><i class="fas fa-link"></i></a>
</h1>
<div id="overview-of-the-bcrabl1-fusion-gene" class="section level2 unnumbered">
<h2>
<strong>Overview of the <em>BCR/ABL1</em> Fusion Gene</strong><a class="anchor" aria-label="anchor" href="#overview-of-the-bcrabl1-fusion-gene"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> The <em>BCR-ABL1</em> fusion gene is an abnormal gene formed by a reciprocal translocation between chromosomes 9 and 22, denoted as t(9;22)(q34.1;q11.2)</li>
<li>
<strong>Historical Context:</strong> This translocation results in the formation of the Philadelphia chromosome (Ph chromosome), named after the city where it was discovered</li>
<li>
<strong>Significance:</strong>
<ul>
<li>Diagnostic Marker for CML: The presence of <em>BCR-ABL1</em> is the defining characteristic of Chronic Myeloid Leukemia (CML)</li>
<li>Prognostic Marker: In CML, the level of <em>BCR-ABL1</em> transcript is used to monitor treatment response and predict the risk of disease progression</li>
<li>Diagnostic and Prognostic Marker for ALL: Present in some cases of Acute Lymphoblastic Leukemia (ALL), particularly adult B-ALL, and is associated with a poorer prognosis</li>
<li>Target for Therapy: The BCR-ABL1 fusion protein is a tyrosine kinase, making it a target for specific tyrosine kinase inhibitors (TKIs)</li>
</ul>
</li>
</ul>
</div>
<div id="molecular-basis-of-the-bcr-abl1-fusion-gene" class="section level2 unnumbered">
<h2>
<strong>Molecular Basis of the <em>BCR-ABL1</em> Fusion Gene</strong><a class="anchor" aria-label="anchor" href="#molecular-basis-of-the-bcr-abl1-fusion-gene"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Normal Genes:</strong>
<ul>
<li>
<em>ABL1</em> (Abelson murine leukemia viral oncogene homolog 1): Located on chromosome 9 (9q34.1)
<ul>
<li>Encodes a non-receptor tyrosine kinase involved in cell growth, differentiation, and survival</li>
</ul>
</li>
<li>
<em>BCR</em> (Breakpoint Cluster Region): Located on chromosome 22 (22q11.2)
<ul>
<li>Encodes a serine/threonine kinase involved in signal transduction</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Translocation Process:</strong>
<ul>
<li>A reciprocal translocation occurs between chromosomes 9 and 22:
<ul>
<li>Part of the <em>ABL1</em> gene from chromosome 9 translocates to the <em>BCR</em> gene on chromosome 22</li>
<li>Part of the <em>BCR</em> gene from chromosome 22 translocates to chromosome 9</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Resulting Fusion Gene:</strong>
<ul>
<li>The translocation creates a new fusion gene, <em>BCR-ABL1</em>, on the Philadelphia chromosome (derivative chromosome 22)</li>
<li>The <em>BCR-ABL1</em> fusion gene encodes a 210 kDa protein that has constitutive tyrosine kinase activity</li>
</ul>
</li>
</ul>
</div>
<div id="pathophysiology-6" class="section level2 unnumbered">
<h2>
<strong>Pathophysiology</strong><a class="anchor" aria-label="anchor" href="#pathophysiology-6"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Constitutive Tyrosine Kinase Activity:</strong>
<ul>
<li>The BCR-ABL1 fusion protein has uncontrolled tyrosine kinase activity, meaning it is always “switched on”</li>
<li>This unregulated kinase activity leads to:
<ul>
<li>Uncontrolled cell proliferation</li>
<li>Inhibition of apoptosis (programmed cell death)</li>
<li>Genomic instability</li>
</ul>
</li>
<li>These effects result in the clonal expansion of malignant myeloid cells (in CML) or lymphoid cells (in Ph+ ALL)</li>
</ul>
</li>
<li>
<strong>Downstream Signaling Pathways:</strong>
<ul>
<li>BCR-ABL1 activates multiple downstream signaling pathways, including:
<ul>
<li>RAS/MAPK pathway</li>
<li>PI3K/AKT pathway</li>
<li>JAK/STAT pathway</li>
</ul>
</li>
<li>These pathways regulate cell growth, survival, and differentiation</li>
</ul>
</li>
</ul>
</div>
<div id="laboratory-detection-of-bcr-abl1" class="section level2 unnumbered">
<h2>
<strong>Laboratory Detection of BCR-ABL1</strong><a class="anchor" aria-label="anchor" href="#laboratory-detection-of-bcr-abl1"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Cytogenetic Analysis (Karyotyping):</strong>
<ul>
<li>
<em>Principle:</em> Visualizes the Philadelphia chromosome (Ph chromosome) resulting from the t(9;22) translocation</li>
<li>
<em>Procedure:</em>
<ul>
<li>Cells are cultured, arrested in metaphase, and stained to visualize the chromosomes</li>
<li>Karyotype is analyzed to identify the Ph chromosome</li>
</ul>
</li>
<li>
<em>Reporting:</em>
<ul>
<li>t(9;22)(q34.1;q11.2)</li>
</ul>
</li>
<li>
<em>Advantages:</em>
<ul>
<li>Can detect other chromosomal abnormalities in addition to the Ph chromosome</li>
</ul>
</li>
<li>
<em>Limitations:</em>
<ul>
<li>Requires viable cells and cell culture</li>
<li>Time-consuming</li>
<li>Cannot detect cryptic translocations or variant translocations</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Fluorescence In Situ Hybridization (FISH):</strong>
<ul>
<li>
<em>Principle:</em> Uses fluorescently labeled DNA probes to detect the <em>BCR</em> and <em>ABL1</em> genes and the <em>BCR-ABL1</em> fusion gene</li>
<li>
<em>Procedure:</em>
<ul>
<li>Interphase FISH: Performed on uncultured bone marrow cells</li>
<li>Metaphase FISH: Performed on cultured cells</li>
<li>Hybridization: Fluorescent probes are hybridized to the chromosomes on a slide</li>
<li>Microscopic Examination: The slide is examined under a fluorescence microscope, and the number and location of the fluorescent signals are counted</li>
</ul>
</li>
<li>
<em>Advantages:</em>
<ul>
<li>More rapid than karyotyping</li>
<li>Can be performed on non-dividing cells</li>
<li>Can detect cryptic translocations</li>
</ul>
</li>
<li>
<em>Limitations:</em>
<ul>
<li>Only detects known chromosomal abnormalities for which probes are available</li>
<li>Cannot detect novel translocations or complex rearrangements</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Reverse Transcription Polymerase Chain Reaction (RT-PCR):</strong>
<ul>
<li>
<em>Principle:</em> Amplifies and detects the <em>BCR-ABL1</em> fusion transcript (mRNA)</li>
<li>
<em>Procedure:</em>
<ol style="list-style-type: decimal">
<li>RNA Extraction: Extract RNA from bone marrow aspirate or peripheral blood</li>
<li>Reverse Transcription: Convert RNA to complementary DNA (cDNA) using reverse transcriptase</li>
<li>Amplification: Use PCR to amplify the <em>BCR-ABL1</em> fusion transcript using specific primers</li>
<li>Detection: Detect the amplified DNA product using gel electrophoresis or real-time PCR</li>
</ol>
</li>
<li>
<em>Qualitative RT-PCR:</em>
<ul>
<li>Detects the presence or absence of the <em>BCR-ABL1</em> transcript</li>
<li>Used for initial diagnosis</li>
</ul>
</li>
<li>
<em>Quantitative Real-Time PCR (RQ-PCR):</em>
<ul>
<li>Measures the level of <em>BCR-ABL1</em> transcript</li>
<li>Used for monitoring minimal residual disease (MRD) and assessing treatment response</li>
<li>Results are typically reported as a percentage of <em>BCR-ABL1</em> transcript relative to a control gene (e.g., <em>ABL1</em> or <em>GUS</em>)</li>
<li>The International Scale (IS) is used to standardize <em>BCR-ABL1</em> transcript levels across different laboratories</li>
</ul>
</li>
<li>
<em>Advantages:</em>
<ul>
<li>High sensitivity and specificity</li>
<li>Can quantify the amount of <em>BCR-ABL1</em> transcript</li>
<li>Rapid turnaround time</li>
</ul>
</li>
<li>
<em>Limitations:</em>
<ul>
<li>Only detects known fusion transcripts for which primers are available</li>
<li>Requires specialized equipment and expertise</li>
<li>Susceptible to contamination</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Next-Generation Sequencing (NGS):</strong>
<ul>
<li>
<em>Principle:</em> Massively parallel sequencing technology that can detect the <em>BCR-ABL1</em> fusion gene and other mutations</li>
<li>
<em>Advantages:</em>
<ul>
<li>Can detect both known and novel fusion genes and mutations</li>
<li>Can identify co-occurring mutations that may affect prognosis or treatment response</li>
</ul>
</li>
<li>
<em>Limitations:</em>
<ul>
<li>More complex and expensive than PCR-based methods</li>
<li>Requires bioinformatics expertise for data analysis</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="clinical-interpretation" class="section level2 unnumbered">
<h2>
<strong>Clinical Interpretation</strong><a class="anchor" aria-label="anchor" href="#clinical-interpretation"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>CML Diagnosis:</strong>
<ul>
<li>A diagnosis of CML requires the presence of the <em>BCR-ABL1</em> fusion gene or the Philadelphia chromosome</li>
<li>The <em>BCR-ABL1</em> transcript level is used to monitor treatment response</li>
</ul>
</li>
<li>
<strong>CML Response to TKI Therapy:</strong>
<ul>
<li>Hematologic Response: Normalization of blood counts</li>
<li>Cytogenetic Response: Reduction or elimination of the Ph chromosome</li>
<li>Molecular Response: Reduction in <em>BCR-ABL1</em> transcript levels, as measured by RQ-PCR
<ul>
<li>Major Molecular Response (MMR): <em>BCR-ABL1</em> transcript level ≤ 0.1% on the International Scale (IS)</li>
<li>Deep Molecular Response (MR4, MR4.5): Very low or undetectable <em>BCR-ABL1</em> transcript levels</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Prognosis:</strong>
<ul>
<li>The level of <em>BCR-ABL1</em> transcript is a key prognostic factor in CML</li>
<li>Patients who achieve a deep molecular response have a lower risk of disease progression</li>
</ul>
</li>
<li>
<strong>Resistance to TKI Therapy:</strong>
<ul>
<li>Mutations in the <em>ABL1</em> kinase domain can lead to resistance to tyrosine kinase inhibitors (TKIs)</li>
<li>
<em>ABL1</em> kinase domain mutation testing is performed to identify resistance mutations and guide treatment decisions</li>
</ul>
</li>
</ul>
</div>
<div id="key-terms-73" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-73"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>BCR-ABL1* Fusion Gene:</strong> A fusion gene created by the translocation between chromosomes 9 and 22, resulting in the Philadelphia chromosome</li>
<li>
<strong>Philadelphia Chromosome (Ph Chromosome):</strong> The derivative chromosome 22 that contains the <em>BCR-ABL1</em> fusion gene</li>
<li>
<strong>Translocation:</strong> The transfer of genetic material from one chromosome to another</li>
<li>
<strong>Tyrosine Kinase Inhibitor (TKI):</strong> A drug that inhibits the activity of tyrosine kinases, such as the BCR-ABL1 protein</li>
<li>
<strong>Minimal Residual Disease (MRD):</strong> Small numbers of residual cancer cells that remain after treatment</li>
<li>
<strong>Major Molecular Response (MMR):</strong> A significant reduction in <em>BCR-ABL1</em> transcript level</li>
<li>
<strong>Deep Molecular Response:</strong> Very low or undetectable <em>BCR-ABL1</em> transcript levels</li>
<li>
<strong>ABL1 Kinase Domain Mutation:</strong> Mutations in the <em>ABL1</em> kinase domain that can cause resistance to TKIs</li>
<li>
<strong>FISH (Fluorescence In Situ Hybridization):</strong> Uses fluorescent probes to identify certain mutations in the body</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();
</script><div class="chapter-nav">
<div class="prev"><a href="recurring-abnormalities.html">Recurring Abnormalities</a></div>
<div class="next"><a href="jak2.html">JAK2</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#bcrabl1">BCR/ABL1</a></li>
<li><a class="nav-link" href="#overview-of-the-bcrabl1-fusion-gene">Overview of the BCR/ABL1 Fusion Gene</a></li>
<li><a class="nav-link" href="#molecular-basis-of-the-bcr-abl1-fusion-gene">Molecular Basis of the BCR-ABL1 Fusion Gene</a></li>
<li><a class="nav-link" href="#pathophysiology-6">Pathophysiology</a></li>
<li><a class="nav-link" href="#laboratory-detection-of-bcr-abl1">Laboratory Detection of BCR-ABL1</a></li>
<li><a class="nav-link" href="#clinical-interpretation">Clinical Interpretation</a></li>
<li><a class="nav-link" href="#key-terms-73">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Hematology/blob/blob/main/book/04-28-laboratory-determinations-molecular-cytogenetic-bcr-abl.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Hematology/blob/edit/main/book/04-28-laboratory-determinations-molecular-cytogenetic-bcr-abl.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-02-28 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
